Article Text

Download PDFPDF
Coronary vasospasm and future percutaneous coronary intervention: relax
  1. Michael McDermott,
  2. Rong Bing
  1. Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK
  1. Correspondence to Dr Rong Bing, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK;{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A clinical diagnosis of suspected angina that is accompanied by non-obstructive epicardial coronary artery disease is not uncommon, as evidenced by results from contemporary registries and trials of anatomical testing in chest pain. The basket labelled as angina with non-obstructive coronary artery disease (ANOCA—the clinical syndrome that may or may not accompany ischaemia with non-obstructive coronary artery disease (INOCA)) contains heterogeneous pathophysiological entities which vary in clinical presentation and adjunctive investigation findings.1 One distinct entry in this field is vasospastic angina, a dynamic phenomenon with characteristic symptoms that differ from those induced by fixed epicardial coronary artery stenoses. Although the seminal case series which provided the eponymous nomenclature for this clinical syndrome was published well before many (probably most) readers of Heart were born, attempts to codify and standardise definitions for vasospastic angina have only recently been promulgated.2 The syndrome is seen in only a small proportion of patients with chest pain, with correspondingly limited sections in current guidelines. 3 4 The diagnostic process can be difficult and the clinical course uncertain. The latter is salient, since, although long-term prognosis is thought to be favourable, there is of course a subset of patients who accrue future adverse events.5

The pathophysiology of coronary vasospasm is still somewhat opaque, but proposed mechanisms, which are unlikely to be discrete and independent, include vascular smooth muscle cell hypercontractility, endothelial dysfunction, low-grade inflammation, oxidative stress, …

View Full Text


  • Twitter @mike_mcdermott1

  • Contributors MM and RB drafted the manuscript and authorised the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles